Romain Larrue
Lille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Correction: Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity.
Journal: The pharmacogenomics journal
Published: July 15, 2025
A Comparison of Molecular Techniques for Improving the Methodology in the Laboratory of Pharmacogenetics.
Journal: International journal of molecular sciences
Published: September 20, 2024
Challenging the narrative of Alport syndrome spectrum: no link with cystic phenotype.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 09, 2024
Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: May 28, 2024
Aging affects reprogramming of pulmonary capillary endothelial cells after lung injury in male mice.
Aging affects reprogramming of pulmonary capillary endothelial cells after lung injury in male mice.
Journal: Nature communications
Published: March 11, 2024
Daily Caffeine Consumption May Increase the Risk of Acute Kidney Injury Related to Platinum-Salt Chemotherapy in Thoracic Cancer Patients: A Translational Study.
Journal: Nutrients
Published: February 28, 2024
MUC1 Drives the Progression and Chemoresistance of Clear Cell Renal Carcinomas.
Journal: Cancers
Published: December 13, 2023
Description of a New Simple and Cost-Effective Molecular Testing That Could Simplify MUC1 Variant Detection.
Journal: Kidney international reports
Published: October 05, 2023
Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity.
Journal: The pharmacogenomics journal
Published: June 15, 2023
miR-92a-3p regulates cisplatin-induced cancer cell death.
Journal: Cell death & disease
Published: March 30, 2023
Last Updated: 09/26/2026